Cardio Diagnostics Holdings (CDIO) Assets (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Assets of $9.6 million for Q1 2026, up 23.09% sequentially from $7.8 million in Q4 2025, and down 22.17% YoY from $12.3 million in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Assets (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Assets for 6 years, with the latest figure at $9.6 million in Q1 2026.
- Quarterly Assets fell 22.17% year-over-year to $9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (down 22.17% YoY) and the FY2025 annual result came in at $7.8 million, down 26.84% from the prior year.
- Assets grew to $9.6 million in Q1 2026 per CDIO's latest filing, from $7.8 million in the prior quarter.
- Over five years, Assets peaked at $65.8 million in Q3 2022 and troughed at $4.0 million in Q2 2024.
- A 5-year average of $17.7 million and a median of $8.6 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2023: Assets surged 467.11% in 2022, then tumbled 90.94% in 2023.
- Over 5 years, Assets stood at $6.2 million in 2022, then decreased by 28.6% to $4.5 million in 2023, then jumped by 137.89% to $10.6 million in 2024, then dropped by 26.84% to $7.8 million in 2025, then advanced by 23.09% to $9.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $9.6 million, $7.8 million, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Cardio Diagnostics Holdings | 6.03 Mn | 443,812.80 | - | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.93 Mn |
| Mar 31, 2026 | 9.56 Mn |
| Dec 31, 2025 | 7.77 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 10.40 Mn |
| Mar 31, 2025 | 12.28 Mn |
| Dec 31, 2024 | 10.62 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 4.46 Mn |
| Sep 30, 2023 | 5.96 Mn |
| Jun 30, 2023 | 6.76 Mn |
| Mar 31, 2023 | 8.55 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 65.80 Mn |
| Jun 30, 2022 | 65.20 Mn |
| Mar 31, 2022 | 65.64 Mn |
| Dec 31, 2021 | 1.10 Mn |